The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Impact in
- Cancer Research 740
Classified as
- Authors
- Can LiuKevin KelnarBigang LiuXin ChenTammy Calhoun‐Davis
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm.2284 →Countries where authors are citing The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
This map shows the geographic impact of The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 more than expected).
Fields of papers citing The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
This network shows the impact of The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
About The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
This paper, published in 2011, received 1.1k indexed citations . Written by Can Liu, Kevin Kelnar, Bigang Liu, Xin Chen, Tammy Calhoun‐Davis, Hangwen Li, Lubna Patrawala, Hong Yan, Collene Jeter and Sofia Honorio covering the research area of Cancer Research and Oncology. It is primarily cited by scholars working on Molecular Biology (812 citations), Cancer Research (740 citations), Oncology (275 citations), Pulmonary and Respiratory Medicine (110 citations) and Immunology (54 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm.2284.